Company intelligence / Profile preview

PETROSEN

New York City, New York, United Statespetrosen.sn ↗

Ownership: Private
Development stage: Other

Overview

Petros Pharmaceuticals has pivoted from a traditional men's health pharmaceutical focus to developing a proprietary SaaS and Software-as-a-Medical Device (SaMD) platform. This technology aims to help pharmaceutical companies transition prescription medications to over-the-counter status by meeting FDA's Additional Conditions for Nonprescription Use guidelines. Eight formative studies have been completed; commercial launch has not occurred.

Therapeutic areas: NeurologyPsychiatryInfectious DiseasesMen's HealthCardiovascular
Modalities: Software as a Medical DeviceSaaS
Industry: Digital Health Medical Devices

Partnerships

Innolitics (technology partner)Unnamed Big Data/analytics provider

Beyond the preview

Go deeper on PETROSEN.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PETROSEN.

Explore the full profile